Functional characterisation of the mesenchymal cell-derived extracellular matrix in myelodysplastic neoplasms

Autor: Bains, Amanpreet Kaur

Myelodysplastic neoplasms (MDS) are a group of heterogeneous, clonal disorders characterised by ineffective haematopoiesis and peripheral blood cytopenia. MDS is highly progressive, difficult to treat, and is one of the most common blood cancers, aff

Externí odkaz: https://ul.qucosa.de/id/qucosa%3A88902
https://ul.qucosa.de/api/qucosa%3A88902/attachment/ATT-0/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes.

Autor: Bains AK; Medical Department I, Haematology and Cell Therapy, University of Leipzig Medical Center, Leipzig, Germany., Behrens Wu L; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany., Rivière J; Department of Medicine III, Hematology/Oncology, School of Medicine, Klinikum rechts der Isar, München, Technical University of Munich, Munich, Germany., Rother S; Center for Molecular Signaling Präklinisches Zentrum für Molekulare Signalverarbeitung (PZMS), Saarland University School of Medicine, Homburg, Germany., Magno V; Max Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Technische Universität (TU) Dresden, Dresden, Germany., Friedrichs J; Max Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Technische Universität (TU) Dresden, Dresden, Germany., Werner C; Max Bergmann Center of Biomaterials, Leibniz Institute of Polymer Research Dresden, Technische Universität (TU) Dresden, Dresden, Germany., Bornhäuser M; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany., Götze KS; Department of Medicine III, Hematology/Oncology, School of Medicine, Klinikum rechts der Isar, München, Technical University of Munich, Munich, Germany., Cross M; Medical Department I, Haematology and Cell Therapy, University of Leipzig Medical Center, Leipzig, Germany., Platzbecker U; Medical Department I, Haematology and Cell Therapy, University of Leipzig Medical Center, Leipzig, Germany., Wobus M; Department of Medicine I, University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Sep 08; Vol. 12, pp. 961473. Date of Electronic Publication: 2022 Sep 08 (Print Publication: 2022).